Zymeworks Inc. (ZYME)

Oct 14, 2025

Will Zymeworks Inc. stock attract ESG investorsQuarterly Portfolio Report & Accurate Buy Signal Alerts - newser.com

Oct 14, 2025

Oct 14, 2025

Zymeworks (NASDAQ:ZYME) Shares Gap UpHere's Why - MarketBeat

Oct 14, 2025

Oct 14, 2025

Zymeworks Inc. (ZYME) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Oct 14, 2025

Oct 14, 2025

HC Wainwright & Co. Upgrades Zymeworks (ZYME) - Nasdaq

Oct 14, 2025

Oct 14, 2025

This RPM International Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga

Oct 14, 2025

Oct 14, 2025

Will Zymeworks Inc. stock sustain high P E ratios2025 Market Outlook & AI Driven Stock Movement Reports - newser.com

Oct 14, 2025

Oct 14, 2025

What the charts say about Zymeworks Inc. today2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - newser.com

Oct 14, 2025

Oct 14, 2025

How Zymeworks Inc. stock compares to market leadersJuly 2025 Gainers & Expert Approved Momentum Trade Ideas - newser.com

Oct 14, 2025

Oct 13, 2025

Will Zymeworks Inc. stock outperform growth indexesQuarterly Performance Summary & Scalable Portfolio Growth Ideas - newser.com

Oct 13, 2025

Oct 13, 2025

Zymeworks to present early data on ZW191 cancer drug at conference - Investing.com Nigeria

Oct 13, 2025

Oct 13, 2025

Zymeworks to present early data on ZW191 cancer drug at conference By Investing.com - Investing.com South Africa

Oct 13, 2025

Oct 13, 2025

Zymeworks Presents Preliminary Phase 1 Results for ZW191 Targeting Advanced Solid Tumors at AACR-NCI-EORTC Conference - Quiver Quantitative

Oct 13, 2025

Oct 13, 2025

Zymeworks to Present Clinical Data from the Phase 1 trial - GlobeNewswire

Oct 13, 2025

Oct 13, 2025

Phase 1 preliminary data: ZW191 (FRα-targeting ADC) — Zymeworks to present at AACR Oct 23 - Stock Titan

Oct 13, 2025

Oct 13, 2025

Zymeworks to Present Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺, at AACR-NCI-EORTC International Conference - Sahm

Oct 13, 2025

Oct 13, 2025

Applying Elliott Wave Theory to Zymeworks Inc.Breakout Watch & Comprehensive Market Scan Reports - newser.com

Oct 13, 2025

Oct 13, 2025

Using economic indicators to assess Zymeworks Inc. potentialOptions Play & Community Consensus Picks - newser.com

Oct 13, 2025

Oct 13, 2025

What technical models suggest about Zymeworks Inc.’s comebackQuarterly Performance Summary & Precise Swing Trade Alerts - newser.com

Oct 13, 2025

Oct 12, 2025

Zymeworks (ZYME): Evaluating Valuation Following New Leadership and Key Regulatory Wins - Sahm

Oct 12, 2025

Oct 12, 2025

Is Zymeworks Inc. showing signs of accumulationForecast Cut & Short-Term Trading Alerts - newser.com

Oct 12, 2025

Oct 12, 2025

Will Zymeworks’ (ZYME) New R&D Leadership Mark a Turning Point in Its Oncology Strategy? - Yahoo

Oct 12, 2025

Oct 11, 2025

Zymeworks (NYSE:ZYME) Stock Price Up 7.2%Here's What Happened - MarketBeat

Oct 11, 2025

Oct 11, 2025

Zymeworks (NASDAQ:ZYME) Reaches New 52-Week HighHere's Why - MarketBeat

Oct 11, 2025

Oct 10, 2025

Zymeworks stock hits 52-week high at 17.71 USD By Investing.com - Investing.com Canada

Oct 10, 2025

Oct 10, 2025

How Might ZYME’s Shifting Leadership Shape Its Late-Stage Oncology Ambitions? - simplywall.st

Oct 10, 2025

Oct 10, 2025

B. Riley Securities Initiates Coverage of Zymeworks (ZYME) with Buy Recommendation - Nasdaq

Oct 10, 2025

Oct 10, 2025

Zymeworks stock hits 52-week high at 17.71 USD - Investing.com

Oct 10, 2025

Oct 10, 2025

Zymeworks (ZYME) Coverage Initiated by B. Riley Securities with 'Buy' Rating | ZYME Stock News - GuruFocus

Oct 10, 2025

Oct 10, 2025

Lifesci Capital Forecasts Zymeworks' Q3 Earnings (NYSE:ZYME) - MarketBeat

Oct 10, 2025

Oct 09, 2025

Zymeworks appoints Adam Schayowitz as acting chief development officer By Investing.com - Investing.com Nigeria

Oct 09, 2025

Oct 09, 2025

Zymeworks Appoints New Acting Chief Development Officer to Boost Therapeutic Advancements - TipRanks

Oct 09, 2025

Oct 09, 2025

Zymeworks appoints Adam Schayowitz as acting chief development officer - Investing.com India

Oct 09, 2025

Oct 09, 2025

Zymeworks Inc. Appoints Adam Schayowitz, Ph.D., MBA as Acting Chief Development Officer - Quiver Quantitative

Oct 09, 2025

Oct 09, 2025

Zymeworks Appoints Dr. Adam Schayowitz as Acting Chief Development Officer - The Spec

Oct 09, 2025

Oct 08, 2025

Q1 Earnings Forecast for Zymeworks Issued By Lifesci Capital - MarketBeat

Oct 08, 2025

Oct 06, 2025

How to forecast Zymeworks Inc. trends using time series2025 Dividend Review & Community Consensus Trade Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

Is Zymeworks Inc a good long term investmentShort-Term Trading Alerts & Small Capital Trading Plans - earlytimes.in

Oct 05, 2025

Oct 05, 2025

Is Zymeworks Inc. stock entering bullish territoryPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - newser.com

Oct 05, 2025

Oct 05, 2025

Why analysts maintain buy rating on Zymeworks Inc. (ZA8) stockJuly 2025 Patterns & Precise Swing Trade Entry Alerts - newser.com

Oct 05, 2025

Oct 05, 2025

Market reaction to Zymeworks Inc.’s recent news2025 Dividend Review & Technical Buy Zone Confirmation - newser.com

Oct 05, 2025

Oct 05, 2025

Key resistance and support levels for Zymeworks Inc.Quarterly Portfolio Review & Reliable Entry Point Alerts - newser.com

Oct 05, 2025

Oct 03, 2025

Zymeworks (ZYME): Assessing Valuation Following Recent Momentum in Biopharma - Sahm

Oct 03, 2025

Oct 03, 2025

Will Zymeworks Inc. stock outperform tech sector in 2025July 2025 Analyst Calls & Scalable Portfolio Growth Ideas - newser.com

Oct 03, 2025

Oct 03, 2025

Will Zymeworks Inc. stock recover faster than peersQuarterly Profit Summary & Daily Volume Surge Signals - newser.com

Oct 03, 2025

Oct 03, 2025

How Zymeworks Inc. (ZA8) stock stacks up against competitorsJuly 2025 Fed Impact & Fast Gain Swing Trade Alerts - newser.com

Oct 03, 2025